Acrivon Therapeutics, Inc.·4

Feb 18, 4:12 PM ET

Miller Mary 4

4 · Acrivon Therapeutics, Inc. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Acrivon (ACRV) CLO Mary Miller Withholds 217 Shares for Taxes

What Happened
Mary Miller, Chief Legal Officer of Acrivon Therapeutics (ACRV), had 217 restricted stock units (RSU) withheld by the company to satisfy mandatory tax withholding upon vesting. The shares were withheld at a per-share value of $1.63, for a total value of approximately $354. This was a tax-withholding disposition (transaction code F), not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-02-14
  • Filing date (Form 4): 2026-02-18
  • Shares affected: 217 shares withheld
  • Withholding price: $1.63 per share; total value ≈ $354
  • Transaction code: F (shares withheld to satisfy tax withholding)
  • Footnote: F1 — Shares withheld by the issuer to satisfy mandatory tax withholding upon RSU vesting.
  • Shares owned after transaction: Not disclosed in the filing
  • Timeliness: Form 4 filed on Feb 18 for a Feb 14 event; the filing shows the trade and withholding but does not indicate any additional timeliness flag.

Context
Tax withholding on RSU vesting is a routine administrative transaction where the issuer retains shares to cover required payroll or income taxes. It does not represent an open-market sale or a discretionary decision to sell shares, and therefore is generally not interpreted as a directional insider trading signal.

Insider Transaction Report

Form 4
Period: 2026-02-14
Miller Mary
Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-14$1.63/sh217$35433,679 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
Signature
/s/ Adam D. Levy, Attorney-in-Fact|2026-02-18

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4